The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation

Cell Mol Immunol. 2019 Aug;16(8):727-729. doi: 10.1038/s41423-019-0238-9. Epub 2019 Jun 3.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Benzoates / pharmacology
  • Benzoates / therapeutic use*
  • Disease Models, Animal
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy*
  • Mice
  • Mice, Inbred C57BL
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Retinoic Acid Receptor alpha / agonists*
  • Tetrahydronaphthalenes / pharmacology
  • Tetrahydronaphthalenes / therapeutic use*
  • Treatment Failure

Substances

  • Anti-Inflammatory Agents
  • Benzoates
  • Neuroprotective Agents
  • Rara protein, mouse
  • Retinoic Acid Receptor alpha
  • Tetrahydronaphthalenes
  • Am 580